StatStrip Glucose Seminars

Consequences of FDA Changes to Critically Ill Bedside Glucose Testing Regulations

Nearly 40% of U.S. hospitals may still be using non-FDA-cleared glucose meters off label with critically ill patients. This seminar will discuss the new FDA requirements for glucose meter use with critically ill patients and the clinical, regulatory, and legal consequences of glucose meter off-label use.